NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseNov 11, 2026 4:00:00 PM EST
41.10USD+0.983%(+0.40)11,553,767
Pre-marketNov 11, 2026 9:28:30 AM EST
40.51USD-0.467%(-0.19)
After-hoursNov 11, 2026 4:58:30 PM EST
41.09USD-0.024%(-0.01)
Loading…
Loading…
181.18B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$40.70
Beta
0.97
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$40.41
SMA 200
$43.48
Avg. Vol 10D
13.25M
Avg. Vol 30D
11.79M
Avg. Vol 90D
12.08M
Relative Vol
0.75
4.41B
3.16B
71.58%
38,286,865
1.21%
4.04
54%/46%
47.18%
28.48%
0.2800%
10,000,000
1,902
13,684
121,034
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Nov 11, 2026
Nov 10, 2026
Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy? · 
The Motley Fool
Is NVO Undervalued? DCF Says Worth $99 · 
GuruFocus
Hims & Hers: 3 Key Takeaways for Long-Term Investors · The Motley Fool
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 42.18 | 2026-11-04 | -2.56% | 1.024 |
| 1M | 38.58 | 2026-10-12 | +6.53% | 0.831 |
| 3M | 47.17 | 2026-08-11 | -12.87% | 0.642 |
| 6M | 46.40 | 2026-05-11 | -11.42% | 0.204 |
| 1Y | 49.15 | 2025-11-11 | -16.38% | 0.971 |
| 2Y | 109.09 | 2024-11-11 | -62.33% | — |
| 5Y | 56.71 | 2021-11-11 | -27.52% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $41.10, and today's volume is 8,845,027. NVO is up 0.983% today. The 30 day average volume is 11.79M. NVO market cap is $181.18B with 4.41B shares outstanding.